Stock Analiz

Chemed Corp. (CHE) stock forecast and price target

Price $548.20 · data as of November 13, 2026

12-month price target

Average target$617.00
Upside / downside+12.6%
Analysts5
ConsensusBuy
Low $580.00Average $617.00High $675.00

Gold marker: average target · white marker: today’s price ($548.20)

Analyst ratings

Strong buy 0Buy 3Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$25.78+19.6%$2.7B
Next fiscal year
ends December 31, 2027
$27.85+8.1%$2.9B
Next quarter
ends December 31, 2026
$7.35+14.5%$712M
Quarter after
ends March 31, 2027
$6.10+8.0%$713M

Consensus of the analysts covering Chemed, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 12.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Chemed’s intrinsic value about 7% below today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Chemed stock price target?

The average 12-month target from 5 analysts is $617.00, 12.6% above the current price of $548.20 Targets range from $580.00 to $675.00.

Is Chemed a buy according to analysts?

The consensus rating is “Buy” (3 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Chemed expected to earn?

Analysts expect EPS of $25.78 for the fiscal year ending December 31, 2026 and $27.85 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.